Close-up TV News - Prolotheray lecture

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

Prolotherapy Interview News 12

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Diabetes and Weight Loss

News 12 Interview: Platelet-rich plasma therapy
Home Articles Viewing article
Cadmium, diabetes and chronic kidney disease

Authors: Joshua R. Edwards, a, and Walter C. Prozialecka
Source: Toxicology and Applied Pharmacology Volume 238, Issue 3, 1 August 2009, Pages 289-293

Abstract
Recent epidemiological studies suggest a positive association between exposure to the environmental pollutant cadmium (Cd) and the incidence and severity of diabetes. In this review, we examine the literature suggesting a relationship between Cd exposure, elevated blood glucose levels, and the development of diabetes. In addition we review human and animal studies indicating that Cd potentiates or exacerbates diabetic nephropathy. We also review the various possible cellular mechanisms by which Cd may alter blood glucose levels. In addition, we present some novel findings from our own laboratories showing that Cd elevates fasting blood glucose levels in an animal model of subchronic Cd exposure before overt signs of renal dysfunction are evident. These studies also show that Cd reduces insulin levels and has direct cytotoxic effects on the pancreas. Together, these findings indicate that Cd may be a factor in the development of some types of diabetes and they raise the possibility that Cd and diabetes-related hyperglycemia may act synergistically to damage the kidney.

View all articles at once